KN Stock Analysis: Knowles Cor | NYSE
Electronic Components | NYSE, USA | Market Cap: 2.851m USD | 12M Return: 39.2% | US49926D1090 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 25.6M
EPS Trend: 82.2%
Qual. Beats: 3
Rev. Trend: 42.8%
Qual. Beats: 0
Warnings
Tailwinds
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Knowles Corporation (NYSE: KN) is a U.S.-based electronic components company that designs and manufactures capacitors, RF and microwave filters, balanced armature speakers, and medtech microphones, operating through two segments: Precision Devices (PD) and Medtech & Specialty Audio (MSA). The PD segment serves defense, industrial, medtech, and electrification/energy markets with high-performance capacitors and RF solutions, while the MSA segment focuses on balanced armature speakers and microphones for hearing health and specialty audio applications in the medtech and industrial sectors. The company sells its products globally through OEMs, contract manufacturers, suppliers, sales representatives, and distributors.
Founded in 1946 and headquartered in Itasca, Illinois, Knowles has been a public company since its 2014 IPO and is classified within the Information Technology sectors Electronic Components sub-industry. Its product portfolio spans film, electrolytic, and mica capacitors used in medtech, defense, and industrial electrification applications, with additional exposure to electric vehicle and communications end markets.
- Defense and EV electrification demand lifts Precision Devices segment
- OTC hearing aid regulation expands MSA market opportunity
- Restructuring drives margin expansion and product mix shift
| Net Income: 67.5m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.06 > 0.02 and ΔFCF/TA -4.16 > 1.0 |
| NWC/Revenue: 35.12% < 20% (prev 29.76%; Δ 5.35% < -1%) |
| CFO/TA 0.10 > 3% & CFO 103.8m > Net Income 67.5m |
| Net Debt (119.8m) to EBITDA (130.5m): 0.92 < 3 |
| Current Ratio: 3.20 > 1.5 & < 3 |
| Outstanding Shares: last quarter (87.9m) vs 12m ago 0.34% < -2% |
| Gross Margin: 42.28% > 18% (prev 40.19%; Δ 2.10% > 0.5%) |
| Asset Turnover: 58.68% > 50% (prev 51.74%; Δ 6.94% > 0%) |
| Interest Coverage Ratio: 12.79 > 6 (EBIT TTM 93.4m / Interest Expense TTM 7.30m) |
| A: 0.21 (Total Current Assets 324.3m - Total Current Liabilities 101.3m) / Total Assets 1.08b |
| B: -0.50 (Retained Earnings -540.3m / Total Assets 1.08b) |
| C: 0.09 (EBIT TTM 93.4m / Avg Total Assets 1.08b) |
| D: 2.84 (Book Value of Equity 795.5m / Total Liabilities 280.5m) |
| Altman-Z'' = 3.28 = A |
| DSRI: 1.02 (Receivables 116.5m/101.1m, Revenue 635.0m/563.1m) |
| GMI: 0.95 (GM 40.19% / 42.28%) |
| AQI: 0.98 (AQ_t 0.55 / AQ_t-1 0.56) |
| SGI: 1.13 (Revenue 635.0m / 563.1m) |
| TATA: -0.03 (NI 67.5m - CFO 103.8m) / TA 1.08b) |
| Beneish M = -2.98 (Cap -4..+1) = A |
As of November 01, 2026, the stock is trading at USD 32.87 with a total of 886,766 shares traded. Over the past week, the price has changed by +2.18%, over one month by -11.92%, over three months by -8.90% and over the past year by +39.16%.
Current recommended Stop Loss: 31.00 (which is 5.7% or 1.3 ATR below the current price).
Knowles Cor has received a consensus analysts rating of 4.25. Therefore, it is recommended to buy KN.
- StrongBuy: 2
- Buy: 1
- Hold: 1
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 44 | 33.9% |
P/E Trailing = 41.725
P/E Forward = 15.2439
P/S = 4.4898
P/B = 3.9436
P/EG = 0.43
Revenue TTM = 635.0m USD
EBIT TTM = 93.4m USD
EBITDA TTM = 130.5m USD
Long Term Debt = 131.0m USD (from longTermDebt, last quarter)
Short Term Debt = 4.50m USD (from shortTermDebt, last quarter)
Debt = 169.4m USD (from shortLongTermDebtTotal, last quarter) + Leases 19.2m
Net Debt = 119.8m USD (calculated: Debt 169.4m - CCE 49.6m)
Enterprise Value = 2.97b USD (2.85b + Debt 169.4m - CCE 49.6m)
Interest Coverage Ratio = 12.79 (Ebit TTM 93.4m / Interest Expense TTM 7.30m)
EV/FCF = 46.78x (Enterprise Value 2.97b / FCF TTM 63.5m)
FCF Yield = 2.14% (FCF TTM 63.5m / Enterprise Value 2.97b)
FCF Margin = 10.0% (FCF TTM 63.5m / Revenue TTM 635.0m)
Net Margin = 10.63% (Net Income TTM 67.5m / Revenue TTM 635.0m)
Gross Margin = 42.28% ((Revenue TTM 635.0m - Cost of Revenue TTM 366.5m) / Revenue TTM)
Gross Margin QoQ = 42.39% (prev 41.28%)
Tobins Q-Ratio = 2.76 (Enterprise Value 2.97b / Total Assets 1.08b)
Interest Expense / Debt = 4.31% (Interest Expense 7.30m / Debt 169.4m)
Taxrate = 14.39% (12.3m / 85.5m)
NOPAT = 80.0m (EBIT 93.4m * (1 - 14.39%))
Current Ratio = 3.20 (Total Current Assets 324.3m / Total Current Liabilities 101.3m)
Debt / Equity = 0.21 (Debt 169.4m / totalStockholderEquity, last quarter 795.5m)
Debt / EBITDA = 0.92 (Net Debt 119.8m / EBITDA 130.5m)
Debt / FCF = 1.89 (Net Debt 119.8m / FCF TTM 63.5m)
Total Stockholder Equity = 775.8m (last 4 quarters mean from totalStockholderEquity)
RoA = 6.24% (Net Income 67.5m / Total Assets 1.08b)
RoE = 8.70% (Net Income TTM 67.5m / Total Stockholder Equity 775.8m)
RoCE = 10.30% (EBIT 93.4m / Capital Employed (Equity 775.8m + L.T.Debt 131.0m))
RoIC = 8.44% (NOPAT 80.0m / Invested Capital 947.5m)
WACC = 10.92% (E(2.85b)/V(3.02b) * Re(11.35%) + D(169.4m)/V(3.02b) * Rd(4.31%) * (1-Tc(0.14)))
Discount Rate = 11.35% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -82.30 | Cagr: -1.29%
[DCF] Terminal Value 64.15% ; FCFF base≈81.9m ; Y1≈71.8m ; Y5≈58.0m
[DCF] Fair Price = 6.28 (EV 655.9m - Net Debt 119.8m = Equity 536.1m / Shares 85.4m; r=10.92% [WACC]; 5y FCF grow -15.0% → 2.50% )
EPS Correlation: 82.22 | EPS CAGR: 10.67% | SUE: 1.32 | # QB: 3
Revenue Correlation: 42.79 | Revenue CAGR: 2.92% | SUE: 0.19 | # QB: 0
EPS current Quarter (2027-03-31): EPS=0.38 | Chg30d=+2.74% | Revisions=+40% | Analysts=2
EPS current Year (2026-12-31): EPS=1.35 | Chg30d=+0.94% | Revisions=+57% | GrowthEPS=+21.4% | GrowthRev=+16.1%
EPS next Year (2027-12-31): EPS=1.65 | Chg30d=+2.16% | Revisions=+29% | GrowthEPS=+22.6% | GrowthRev=+5.3%
[Analyst] Revisions Ratio: +62% (up=9, down=1)